Researchers have made significant strides in reversing skin aging by targeting harmful compounds that accumulate in tissues over time. These compounds, formed through a process called glycation, occur when sugars react with proteins, leading to impaired tissue function, particularly affecting collagen, which is crucial for skin and blood vessel integrity. One notable glycation product, carboxymethyllysine (CML), has been linked to increased mortality risk and is traditionally difficult to eliminate from damaged proteins. However, a team of scientists has developed an innovative enzyme named CMLase, capable of identifying and removing CML. In their study, the researchers screened through over 500 million enzyme variants to find the right candidate. During experiments, CMLase was applied to thin slices of skin taken from an elderly donor, resulting in a remarkable reduction of CML levels by over 55% overnight, achieving levels even lower than those seen in samples from 31-year-olds. Additionally, in artery tissue from a 75-year-old donor, CML levels decreased by more than 70%. While this advancement marks a significant step in addressing age-related damage in laboratory settings, it remains to be seen if this enzyme can be safely utilized in living organisms. As discussions about the potential for an "anti-aging pill" continue, opinions are divided on whether such a breakthrough will ever be realized.
Informational material. 18+.
